Prostatic Neoplasms: all 6,484 studies
Page 34 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates CancerCompletedNCT04801186
- Expanded Access [Ga-68] PSMA-11 PET ImagingNo longer availableNCT04800068
- US/MRI Fusion Local Anestesia TransPerineal Prostate Biopsies for Detection of Prostate CancerWithdrawnNCT04797078Not applicable
- 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer PatientsStatus unknownNCT04796467Phase 2/3
- Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.Status unknownNCT04792138
- Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer PatientsCompletedNCT04790968Not applicable
- Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT StudyCompletedNCT04789018
- Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)Active, not recruitingNCT04788277
- Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerActive, not recruitingNCT04787744Phase 2/3
- 177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry StudyCompletedNCT04786847Phase 1
- To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female VolunteersStatus unknownNCT04783636Phase 1
- Smart Prostate Specific Antigen (PSA) Screening StudyCompletedNCT04782713Not applicable
- Neratinib in Patients With Metastatic Castration-Resistant Prostate CancerWithdrawnNCT04781374Phase 2
- An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate CancerActive, not recruitingNCT04777071Phase 2
- The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer PatientsCompletedNCT04776889Phase 4
- Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer.CompletedNCT04775602Phase 2
- The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.Status unknownNCT04774133Not applicable
- Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal TherapyStatus unknownNCT04773821Not applicable
- ProsTIC Registry of Men Treated With PSMA TheranosticsActive, not recruitingNCT04769817
- PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate CancerCompletedNCT04768608Phase 1
- DISCO: A Patient Intervention to Reduce the Financial Burden of CancerActive, not recruitingNCT04766190Not applicable
- Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic DiseaseWithdrawnNCT04765423Not applicable
- Improving Care After Inherited Cancer TestingActive, not recruitingNCT04763915Not applicable
- Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate CancerTerminatedNCT04754425Phase 2
- Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)CompletedNCT04751201Not applicable
- Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)Active, not recruitingNCT04748042Phase 2
- Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26CompletedNCT04746638Phase 1
- imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGSStatus unknownNCT04746300
- Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).TerminatedNCT04745871Not applicable
- Prostate PMSABR StudyWithdrawnNCT04742972Not applicable
- Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerCompletedNCT04742361Phase 3
- Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the ProstateStatus unknownNCT04736108Phase 2
- A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate CancerStatus unknownNCT04734184Phase 3
- 18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate CancerCompletedNCT04733768Phase 2
- Testing the Effect of Mindfulness for Prostatectomy OutcomesTerminatedNCT04727710Not applicable
- Family History App in Personalized MedicineCompletedNCT04726319Not applicable
- 64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)CompletedNCT04726033Early Phase 1
- 12 Fractions Carbon Ion Radiotherapy for Localized Prostate CancerStatus unknownNCT04724577Not applicable
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Active, not recruitingNCT04720157Phase 3
- A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate CancerActive, not recruitingNCT04709276Phase 2
- Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone TreatmentsCompletedNCT04705038Not applicable
- Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate TumorsCompletedNCT04704804
- Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian CancerCompletedNCT04703920Phase 1
- Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate CancerCompletedNCT04703543Not applicable
- Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate CancerCompletedNCT04702633
- TENDU Vaccine in Patients With Relapse After Primary Radical ProstatectomyCompletedNCT04701021Phase 1
- A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma DiagnosisStatus unknownNCT04699344
- Single-Port Versus Multi-Port Robotic Radical ProstatectomyWithdrawnNCT04696263Not applicable
- Multimedia-based Hormonal Therapy Information Program for Patients With Prostate CancerCompletedNCT04693910Not applicable
- [Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer PatientsActive, not recruitingNCT04693169Not applicable
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT04691804Phase 3
- Multimodal Machine Learning Characterization of Solid TumorsCompletedNCT04687969
- To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer PatientsCompletedNCT04687709
- Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate CancerStatus unknownNCT04686188
- Extended Systematic Versus Mri-Assisted pRostate Transperineal BiopsyCompletedNCT04685928Not applicable
- 68Ga-PSMA PET/CT in Prostate CancerSuspendedNCT04684628Phase 3
- A Study to Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its SafetyCompletedNCT04681144
- Study of PCUR-101 in Combination With ADT in Patients With mCRPCTerminatedNCT04677855Phase 1
- SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT04676607Phase 2
- The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and OmeprazoleCompletedNCT04676035Phase 1
- Drug-drug Interaction of SHR3680 With Repaglinide and BupropionStatus unknownNCT04664725Phase 1
- 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate CancerActive, not recruitingNCT04663997Phase 2
- Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAsCompletedNCT04662996Not applicable
- ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate CancerActive, not recruitingNCT04662580Phase 1
- Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto RicoActive, not recruitingNCT04661176
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsActive, not recruitingNCT04660929Phase 1
- A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)Status unknownNCT04660617
- Insulin Resistance Following ADT for Prostate CAWithdrawnNCT04658849Early Phase 1
- Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.CompletedNCT04655365Phase 2
- Surgical and Functional Outcomes of Rectourethral Fistulas Surgery With Gracilis Flap Interposition After Localized Prostatic Cancer Treatment.CompletedNCT04654715
- Evaluation of Atherosclerotic Plaques in Abdominal CT StudiesActive, not recruitingNCT04652973
- Mental Wellbeing and Quality of Life in Prostate CancerCompletedNCT04647474
- Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical ProstatectomySuspendedNCT04646434Not applicable
- A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only RecurrenceWithdrawnNCT04645810Not applicable
- Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.CompletedNCT04644822Phase 3
- A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate CancerActive, not recruitingNCT04644770Phase 1
- Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesActive, not recruitingNCT04644068Phase 1/2
- Prostate Cancer in Renal Transplants RecipientsStatus unknownNCT04642833
- Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)CompletedNCT04638049Not applicable
- Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPCTerminatedNCT04634344Phase 1
- Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate CancerStatus unknownNCT04632251Not applicable
- Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPCTerminatedNCT04629781Phase 1
- A Study of CC-90011 and Comparators in Participants With Prostate CancerCompletedNCT04628988Phase 1
- STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate CancerCompletedNCT04627948
- Targeted Microwave Focal TherapyCompletedNCT04627896Phase 2/3
- Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRTActive, not recruitingNCT04624828Not applicable
- Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA TrialActive, not recruitingNCT04624256Not applicable
- Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate CancerActive, not recruitingNCT04619069Phase 1/2
- A Phase 1 Study of Autologous Dendritic Cell Immunotherapy in Patients With mCRPCTerminatedNCT04615845Phase 1
- Internal Carotid Artery Blood Flow in Robot-Assisted Laparoscopic ProstatectomyCompletedNCT04615494
- Threedimensional Multiparametric Ultrasound for Prostate Cancer DetectionCompletedNCT04605276
- A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPCStatus unknownNCT04603833Phase 2
- FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR PRIMARY LOCALIZED PROSTATE CANCER: MIDTERM ONCOLOGICAL OUTCOMESCompletedNCT04602208
- Integrated Boost to the Dominant Intraprostatic Nodule Based on Ga-68 PSMA PET/MR Study of SBRT With Prostate CancerStatus unknownNCT04599699Not applicable
- Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate CancerActive, not recruitingNCT04597411Phase 1
- To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringActive, not recruitingNCT04597359Phase 2
- Music Listening as a Postanesthesia Care Unit (PACU) Nursing InterventionCompletedNCT04596917Not applicable
- Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.CompletedNCT04593420
- Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate CancerActive, not recruitingNCT04592237Phase 2
- Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative ResearchCompletedNCT04590976